Corcept Therapeutics
CORT
CORT
212 hedge funds and large institutions have $1.45B invested in Corcept Therapeutics in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 66 increasing their positions, 68 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.33% less ownership
Funds ownership: 77.88% → 76.55% (-1.3%)
10% less capital invested
Capital invested by funds: $1.61B → $1.45B (-$159M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
212
Holding in Top 10
4
Calls
$10.8M
Puts
$9.82M
Top Buyers
| 1 | +$24.8M | |
| 2 | +$17.2M | |
| 3 | +$13.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$9.15M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$7.83M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$15.2M | |
| 3 | -$12.7M | |
| 4 |
TA
Teachers Advisors
New York
|
-$10.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.2M |